Navigation Links
Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
Date:6/21/2013

SAN DIEGO and IRVINE, Calif., June 21, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTCQB: SRNE; Sorrento) and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq™) and IG-004 (TOCOSOL® paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine (CLINAM) and the European Technology Platform on Nanomedicine (ETPN) in Basel, Switzerland on June 23 - 26. Sorrento has the right to acquire IGDRASOL pursuant to a previously-announced option agreement, entered into in March 2013.

IGDRASOL'S data mining of the clinical data for both IG-001 and IG-004 has generated exciting insights into the field of nanomedicine, which will be presented at the joint meeting. These findings are highly relevant to the theme of this year's conference, namely "Nanomedicine & Targeted Medicine – the paradigm of precise, highly effective and innocuous medicine for the benefit of patients and mankind".

IG-001 (Cynviloq™) is a next-generation, branded, micellar diblock copolymeric paclitaxel formulation currently approved and marketed in several countries as Genexol-PM®. It has completed Phase 1 or 2 trials in metastatic breast cancer (MBC), non-small cell lung cancer (NSCLC), pancreatic cancer, ovarian cancer and bladder cancer in the U.S. and/or ex-U.S. IGDRASOL is preparing for an "End of Phase 2" meeting scheduled with the U.S. Food & Drug Administration (FDA) in July 2013, regarding the clinical development of Cynviloq™. As an injectable nanoparticle formulation of paclitaxel, Cynviloq™ may be eligible for approval through the FDA's 505(b)(2) bioequivalence regulatory pathway versus albumin-bound paclitaxel (nab-paclitaxel; Abraxane®) in its currently approved MBC and NSCLC ind
'/>"/>

SOURCE Sorrento Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sorrento Therapeutics Receives Frost & Sullivans Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
2. Sorrento Therapeutics Receives Frost & Sullivans 2013 Global Investment Opportunity Award in Oncology
3. Sorrento Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference in New York City
4. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
5. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
6. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
7. Sorrento Therapeutics Awarded Third Phase I STTR Grant
8. Orexigen Therapeutics Announces Upcoming Clinical Data Presentations at American Diabetes Association Annual Scientific Meeting
9. Echo Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Over-Allotment Option by the Underwriter
10. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
11. Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , July 25, 2014 Leading events ... is returning for the seventh year to São Paulo, ... th August 2014. The event will co-locate with Food ... most comprehensive meeting point for the pharmaceutical industry. ... 25 countries for pharmaceutical sales are now exploring the ...
(Date:7/25/2014)... Dr. Michael Gabriel of a prominent Staten ... study, which shows how grief in pregnancy may cause obesity ... According to US News , "Unborn children ... others to grow up overweight or obese, even if that ... specific types of stress that caused obesity: "Children whose biological ...
(Date:7/24/2014)... July 24, 2014  PTC Therapeutics, Inc. (NASDAQ: ... host a webcast conference call to report its second ... the company,s business and outlook on Thursday, August 7, ... the market. The call can be ... (international) five minutes prior to the start of the ...
Breaking Medicine Technology:CPhI South America 2014 Launches with Generics Showing Huge Growth 2CPhI South America 2014 Launches with Generics Showing Huge Growth 3CPhI South America 2014 Launches with Generics Showing Huge Growth 4Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2
... Inc. joined the National Senior Games Association to launch the ... a global leader in musculoskeletal health, Zimmer is proud to ... athletic achievements of 356 athletes assembled for this year,s winter ... year,s games as they demonstrate what can be achieved by ...
... Sysmex America, Inc., a global leader in ... today announces the release of the newest version ... The Sysmex WAM Management Reports Module features new ... enable the user to quickly develop on-demand reports, ...
Cached Medicine Technology:Zimmer Sponsors Winter National Senior Games 2Sysmex Announces Newest Version of Clinical Laboratory Management Software 2
(Date:7/28/2014)... TherapySites, the leading website ... today its affiliation with the Illinois Association for ... allows TherapySites to continue to extend their online marketing ... offers. , “There has been a fundamental shift in ... nearly 3 billion Internet users, it is so important ...
(Date:7/28/2014)... July 28, 2014 Footwear etc. is ... styles from Mephisto. With shoes, sandals, and boots that ... products continually provide handmade comfort shoes and ... women have come to rely on the superb value, ... Mephisto shoes and sandals contain the highest quality materials ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 To commemorate ... Editorial Board of Living with a Disability magazine ... disabling digestive disorders that include hepatitis, gastrointestinal hemorrhage, inflammatory ... , The important new article highlights that, in the ... afflicted with hepatitis and other disabling conditions related to ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 According to the ... a comprehensive relationship guide that helps women easily get the ... , Vkool reveals in its review that this book ... eyes of their man. The book also instructs them how ... Vkool informs in its Drama Method review that this book ...
(Date:7/28/2014)... Suwanee, GA (PRWEB) July 28, 2014 ... across the nation gathered at the MGE Management Experts ... officials and community leaders joined the Dentists to raise ... of the Boys and Girls Clubs and Youth Programs ... thousands of young people with books and audio books ...
Breaking Medicine News(10 mins):Health News:TherapySites (Websites for Therapists) Partners with the Illinois Association for Marriage and Family Therapy 2Health News:Footwear etc. Highlights Phenomenal Models of Mephisto Shoes 2Health News:Footwear etc. Highlights Phenomenal Models of Mephisto Shoes 3Health News:Living with a Disability Magazine Marks World Hepatitis Day on July 28 with New Article on Disabling Digestive Disorders 2Health News:Living with a Disability Magazine Marks World Hepatitis Day on July 28 with New Article on Disabling Digestive Disorders 3Health News:The Drama Method Pdf Review Exposes Aaron Fox's Relationship Guide – Vkool.com 2Health News:The Drama Method Pdf Review Exposes Aaron Fox's Relationship Guide – Vkool.com 3Health News:Mitul R. Patel, DDS Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 2Health News:Mitul R. Patel, DDS Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 3
... a new study from the Journal of Bone and ... fasciitis who perform manual plantar fasciitis stretching exercises, as opposed ... Study details and findings: , A ... were randomly assigned to two groups. Acute is defined ...
... Nov. 3 (HealthDay News) -- Friendly discussions with other people ... are competitive in tone aren,t helpful, finds a new study. ... the way you do when you,re making friends, can provide ... at the Institute for Social Research at the University of ...
... a new clinical practice guideline for the nutritional and ... with diabetes mellitus. The guideline features a series of ... The guideline is published in the November 2010 issue ... ( JCEM ), a publication of The Endocrine ...
... HealthDay Reporter , WEDNESDAY, Nov. 3 (HealthDay News) ... treatment for men with prostate cancer, use declined drastically. ... -- androgen-deprivation therapy -- still received it, researchers report in ... of Medicine . "Probably what we,re witnessing here is ...
... CINCINNATIResearchers at the University of Cincinnati (UC) and the Cincinnati ... of chronic kidney disease patients who are prescribed therapies for ... This report was published in the Nov. 2 online edition ... study, led by researchers at UC and the Cincinnati VA, ...
... Stereotactic body radiotherapy (SBRT), a radiation therapy procedure pioneered ... precisely delivers a large dose of radiation to tumors, ... when combined with the chemotherapy Cetuximab, according to researchers ... presented today at the American Society for Radiation Oncology ...
Cached Medicine News:Health News:Plantar fasciitis? Stretching seems to do the trick 2Health News:Good Conversation Can Boost Brain Power, Study Finds 2Health News:Experts issue recommendations for treatment of post-bariatric surgery patients 2Health News:Use of Prostate Cancer Treatment Fell When Medicare Paid Docs Less 2Health News:Use of Prostate Cancer Treatment Fell When Medicare Paid Docs Less 3Health News:Medication adherence improves blood pressure control in chronic kidney disease 2Health News:Combining radiation therapy, chemotherapy safely treats head and neck cancer patients 2
... and balanced for smooth, one-handed control. Reflexion's ... reducing fatigue in even the longest procedures. ... to easily steer the catheter through its ... finger. Reflexion's auto-lock technology keeps the catheter ...
... technologies - Quantum™ LEAP® balloon material ... unite in the Quantum™ Maverick® Balloon ... force balloon with exceptional deliverability. Easier ... shaft technology improves trackability and crossability ...
... Libert Coronary Stent System ... of lesion access and ... a low crossing profile, ... catheter, the performance of ...
... colonies, rows, and microplatesthat is the area ... is becoming an ever-increasing force. Ergonomics (reduced ... main reason that the Multichannel Research model ... pipette provides effective, precise, and rapid processing ...
Medicine Products: